We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The drug price “negotiations” in the 2022 Inflation ... At the same time, the political appeal of Medicare reducing drug prices is significant. The optics of wiping out the price-setting ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

An early move by the president has raised questions about what direction his second-term policy on drug costs will take.

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

In what appears to be a response to manufacturer complaints regarding “black box” Inflation Reduction Act (IRA) drug price negotiations, the ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.